CN101850000B - Chinese and western medicinal composition for treating empyrosis - Google Patents
Chinese and western medicinal composition for treating empyrosis Download PDFInfo
- Publication number
- CN101850000B CN101850000B CN2010102056751A CN201010205675A CN101850000B CN 101850000 B CN101850000 B CN 101850000B CN 2010102056751 A CN2010102056751 A CN 2010102056751A CN 201010205675 A CN201010205675 A CN 201010205675A CN 101850000 B CN101850000 B CN 101850000B
- Authority
- CN
- China
- Prior art keywords
- parts
- burn
- chinese
- western
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 45
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003610 charcoal Substances 0.000 claims abstract description 12
- 229940105082 medicinal charcoal Drugs 0.000 claims abstract description 12
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims abstract description 11
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 claims abstract description 9
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 claims abstract description 9
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960002867 griseofulvin Drugs 0.000 claims abstract description 9
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 claims abstract description 9
- 235000019366 oxytetracycline Nutrition 0.000 claims abstract description 7
- 229940097572 chloromycetin Drugs 0.000 claims description 7
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 230000035876 healing Effects 0.000 abstract description 24
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 208000002193 Pain Diseases 0.000 abstract description 7
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 abstract description 6
- 229960001625 furazolidone Drugs 0.000 abstract description 6
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract description 6
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract description 5
- 229930003471 Vitamin B2 Natural products 0.000 abstract description 5
- 229960002477 riboflavin Drugs 0.000 abstract description 5
- 239000011716 vitamin B2 Substances 0.000 abstract description 5
- 235000019164 vitamin B2 Nutrition 0.000 abstract description 5
- 229960005091 chloramphenicol Drugs 0.000 abstract description 4
- 239000004100 Oxytetracycline Substances 0.000 abstract description 3
- 210000000981 epithelium Anatomy 0.000 abstract description 3
- 229960000625 oxytetracycline Drugs 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000017423 tissue regeneration Effects 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 241000406668 Loxodonta cyclotis Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract 1
- 230000001360 synchronised effect Effects 0.000 abstract 1
- 230000008719 thickening Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 23
- 206010052428 Wound Diseases 0.000 description 21
- 229920000742 Cotton Polymers 0.000 description 17
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 16
- 239000006071 cream Substances 0.000 description 10
- 210000003097 mucus Anatomy 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 229960003276 erythromycin Drugs 0.000 description 8
- 210000001364 upper extremity Anatomy 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- CIKWKGFPFXJVGW-UHFFFAOYSA-N ethacridine Chemical compound C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 CIKWKGFPFXJVGW-UHFFFAOYSA-N 0.000 description 5
- 229960001588 ethacridine Drugs 0.000 description 5
- 238000007667 floating Methods 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 5
- 206010051814 Eschar Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 231100000333 eschar Toxicity 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- OWFJMIVZYSDULZ-PXOLEDIWSA-N (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O OWFJMIVZYSDULZ-PXOLEDIWSA-N 0.000 description 3
- 208000009043 Chemical Burns Diseases 0.000 description 3
- 208000018380 Chemical injury Diseases 0.000 description 3
- 206010031264 Osteonecrosis Diseases 0.000 description 3
- 210000000589 cicatrix Anatomy 0.000 description 3
- 238000010891 electric arc Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000003345 natural gas Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- 208000003656 Electric Burns Diseases 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 241000606701 Rickettsia Species 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 208000001435 Thromboembolism Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000007287 cheilitis Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229940127017 oral antidiabetic Drugs 0.000 description 2
- 239000003538 oral antidiabetic agent Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000555268 Dendroides Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 241000605008 Spirillum Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- -1 electric current Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229930185127 geomycin Natural products 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000438 stratum basale Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000009862 superficial mycosis Diseases 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of Chinese and western medicinal compounds, and in particular relates to a Chinese and western medicinal composition for treating empyrosis, which comprises the following Chinese medicaments or western medicaments in part by weight: 80 to 120 parts of golden thread, 800 to 1,200 parts of medicinal charcoal, 8 to 12 parts of borneol, 80 to 120 parts of elephant's hide, 60 to 90 parts of chloramphenicol, 3 to 7 parts of vitamin B2, 80 to 120 parts of furazolidone, 230 to 270 parts of oxytetracycline and 30 to 70 parts of griseofulvin. The Chinese and western medicinal composition can stop pain quickly, clear away heat and toxic materials, eliminate stasis to subdue swelling, remove slough and promote the growth of tissue regeneration and repair tissue epithelium quickly, has high cure rate and low cost (the cost is 1/20 of regular hospitals), and is not limited by prophetical environment during treatment; and particularly, the Chinese and western medicinal composition has the unique advantage on the aspect of treating diabetes empyrosis patients, namely the blood sugar is not needed to be controlled, the patients are bound up by thickening, the healing time is shortened greatly, and the diabetes empyrosis patients can be basically synchronous with normal empyrosis patients.
Description
Technical field
The invention belongs to Chinese medicine and western medicine compound recipe technical field, specifically disclose a kind of Chinese and western medicinal composition for the treatment of burn.
Background technology
Burn is damage common in daily life, the productive labor, is to act on the caused damage of human body by flame, steam, hot liquid, electric current, chemical substance etc.Especially in the surrounding area, oil field, surrounding is oil, natural gas everywhere, and cooking all is with the packed natural gas of plastics, is easy to that burn takes place and mostly is large-area burns, goes hospitalize, is difficult to bear at most extremely medical expense up to a million of hundreds of thousands.In addition, diabetes are a kind of whole body chronic metabolic disease, easily produce a series of complication.Especially the long gerontal patient of the course of disease, when peripheral neuropathy, the acra respond lowers or forfeiture, and the source autoreactivity of causing injury is descended, and protective is poor, and old people's bradykinesia is then easier to be injured in addition.Diabetics is a special social group, along with modern society's expanding economy, and the aging of society, diabetics is on the increase, and the diabetics burn is in rising trend.The content of sugar increases in the wound exudate of the emergent back of diabetes burn patient, and burn wound infects also can be than ordinary person's incidence rate height, and this has just brought very big resistance to treatment.Yet with the drug treatment of diabetic fire victim of present existing treatment burn, effect is not satisfactory, not only needs blood sugar control, and healing time often will be longer than normal fire victim's healing time.
Summary of the invention
For overcoming the deficiencies in the prior art part, purpose of the present invention just is to provide a kind of Chinese and western medicinal composition of eutherapeutic treatment burn.
For achieving the above object, the technical scheme taked of the present invention is as follows:
A kind of Chinese and western medicinal composition for the treatment of burn is made up of following parts by weight of traditional Chinese medicines or Western medicine: 80～120 parts of Rhizoma Coptidis, 800～1200 parts of medicinal charcoal, 8～12 parts of Borneolum Syntheticums, 80～120 parts of big Corium elephatiss, 60～90 parts in chloromycetin, 3～7 parts of vitamin Bies, 80～120 parts of furazolidones, 230～270 parts of oxytetracyclines, 30～70 parts of griseofulvin.
Preferably, form by following parts by weight of traditional Chinese medicines or Western medicine: 100 parts of Rhizoma Coptidis, 1000 parts of medicinal charcoal, 10 parts of Borneolum Syntheticums, 100 parts of big Corium elephatiss, 75 parts in chloromycetin, 3 parts of vitamin Bies, 100 parts of furazolidones, 250 parts of oxytetracyclines, 50 parts of griseofulvin.
Described medicinal charcoal replaces with the agysical that contains the equivalent medicinal charcoal.Agysical is made of kaolin, medicinal charcoal, silver chloride and appropriate amount of auxiliary materials.
Described big Corium elephatis is the big Corium elephatis of concocting.Concocting method is this area routine techniques, referring to the record of " Kaibao Bencao " or " China's book on Chinese herbal medicine " lining.
Pharmacology of the present invention: Rhizoma Coptidis: heat clearing and damp drying, eliminating fire and detoxication, also play antibacterial action, anti-staphylococcus aureus, Hemolytic streptococcus, streptococcus pneumoniae, meningococcus, dysentery bacterium, anthrax bacillus; Medicinal charcoal: as additive; Borneolum Syntheticum: function cures mainly logical all keys, the stagnated fire of loosing, and removing nebula makes eye bright, and reducing swelling and alleviating pain is controlled apoplexy locked mouth, calentura coma, infantile convulsion expectorant fan, deafness with qi stagnation, sore throat, aphtha, otitis media, carbuncle, hemorrhoid, order also nebula film, enterobiasis; Big Corium elephatis: promote skin growth; Chloromycetin, the tool broad-spectrum antibacterial action, generally strong than gram positive bacteria to the gram negative bacteria effect, sensitive organism has enterobacteriaceae lactobacteriaceae (as escherichia coli, clostridium perfringen, klebsiella, Salmonella etc.) and anthrax bacillus, streptococcus pneumoniae, streptococcus, listeria spp, staphylococcus etc., chlamydia, leptospira, rickettsia are also to the chloromycetin sensitivity, and chloromycetin also has suitable effect to anaerobe such as clostridium tetani, bacillus perfringens, actinomycetes and lactobacillus, Fusobacterium etc.; Vitamin B2: promote cell regeneration, impel the skin normal growth, eliminate the inflammation at mouthful, and external genitalia official position, as angular cheilitis, cheilitis, glossitis, eye conjunctivitis and scrotitis etc.; Furazolidone: have another name called furazolidone, anti-general bacterium, similar furan because of, the most responsive to escherichia coli, dysentery bacterium etc.; Oxytetracycline: have another name called geomycin or oxytetracycline, antibiotics a kind of, multiple coccus and bacillus are had antibacterial action, and antimicrobial spectrum is similar to tetracycline, and is all effective to most gram positive bacterias, negative bacterium, rickettsia, chlamydia trachomatis, actinomycetes and spirillum etc.; Griseofulvin: superficial mycosiss such as trichophyta, sporidiole bacteria, epidermophyton are had good antibacterial action.More than the mutual compatibility of all medicines, play heat-clearing and toxic substances removing altogether, relieve the pain, putrefaction-removing granulation-promoting, provide the effect of nutrition, blood circulation promoting, acceleration epithelium regeneration to wound surface.
Preparation method: medicament mixed of the present invention is mixed even, grind into fine powder, cross 200 mesh sieves and get final product.
Therapeutic Method:
(1) exposes Sex therapy
Be applicable to any position that do not suffer oppression (air themperature is at 22～40 ℃) of head, face, cervical region.
I degree burn: spread 0.5～1.0 millimeter medicine of the present invention after being coated with sticking medicament (as erythromycin cream or burn analgesic extract etc.), can heal in 3～7 days.
Shallow II degree burn: peeling, treatment form grey black mucus with I degree burn under the crust after three days, women's head-ornaments portion can heal in 5～7 days, and the upper limb trunk can be healed in 8～11 days, and lower limb can be healed in 10～12 days.
Dark II degree or III degree burn: peeling, treatment was changed dressings once with I degree burn in 8～12 days, removed floating crust when changing dressings, and gently was stained with unnecessary mucus but wound surface not capable of washing with absorbent cotton, and healing time is relevant with the wound surface size depth, but repeatable operation, until healing.
(2) occlusive dressing
Be applicable to head, face, cervical region any position in addition, be not subjected to the restriction of temperature and external environment.
Therapeutic Method is basic with exposing Sex therapy, difference is, application ethacridine gauze one deck (this gauze and medicine Fails To Respond of the present invention again on medicine of the present invention, purpose separates medicine of the present invention and Cotton Gossypii), add a cover 0.2～0.6 centimetre of aseptic cotton again and cover, be integrated with gauze, wrapping linear slit.I degree burn once can be healed in 3～7 days, and shallow II degree burn once can be healed in 8～12 days, and dark II degree or III degree burn were changed dressings once in 10～15 days, can use repeatedly until recovery from illness, to the osteonecrosis patient in conjunction with operative treatment.
Beneficial effect of the present invention: the present invention can quick pain relief, heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling, putrefaction-removing granulation-promoting, quick repair tissue epithelium, the cure rate height, expense low (only be regular hospital 1/20) is not limited by surrounding enviroment during the treatment, especially aspect treatment diabetes fire victim, has its special advantages, do not need blood sugar control, healing time has very big shortening, can with normal fire victim's basic synchronization.
The specific embodiment
Below in conjunction with specific embodiment technical scheme of the present invention is done into a ground and introduce in detail, but protection scope of the present invention is not limited thereto:
Embodiment 1
Rhizoma Coptidis 100g, medicinal carbon plate 1000g, Borneolum Syntheticum 10g, the process of preparing Chinese medicine big Corium elephatis 100g, Chloramphenicol Tablets 75g, vitamin B2 sheet 3g, furaxone 100g, hydroxytetracycline tablet 250g, griseofulvin tablet 50g.Above nine herbal medicines are mixed mix evenly, grind into fine powder, cross 200 mesh sieves and get final product.
Embodiment 2
Rhizoma Coptidis 80g, the agysical sheet that contains the 800g medicinal charcoal, Borneolum Syntheticum 8g, the process of preparing Chinese medicine big Corium elephatis 80g, Chloramphenicol Tablets 60g, vitamin B2 sheet 5g, furaxone 80g, hydroxytetracycline tablet 230g, griseofulvin tablet 30g.Above nine herbal medicines are mixed mix evenly, grind into fine powder, cross 200 mesh sieves and get final product.
Embodiment 3
Rhizoma Coptidis 120g, medicinal carbon plate 1200g, Borneolum Syntheticum 12g, the process of preparing Chinese medicine big Corium elephatis 120g, Chloramphenicol Tablets 90g, vitamin B2 sheet 7g, furaxone 120g, hydroxytetracycline tablet 270g, griseofulvin tablet 70g.Above nine herbal medicines are mixed mix evenly, grind into fine powder, cross 200 mesh sieves and get final product.
Clinical trial
One, basic document (1 day to 2009 January in 2009, on December 31)
Normal fire victim is totally 1169 examples: wherein male 805 examples, women 364 examples, 4～80 years old age, 42 years old mean age, maximum burn surface area 86%.I degree 224 examples, shallow II degree 413 examples, dark II degree 343 examples, III degree 189 examples.Burn position: upper limb 493 examples, lower limb 371 examples, women's head-ornaments portion 113 examples, trunk 192 examples.Burn cause: hydrothermal solution is scalded 383 examples, steam and is scalded 115 examples, flame burn 154 examples, low temperature burn 202 examples, electric arc and hinder 124 examples, electric burn 50 examples, chemical burn 141 examples.0.5 hour～150 days burn time.
Diabetes fire victim is totally 173 examples: wherein male 61 examples, women 112 examples, 34～82 years old age, 58 years old mean age, burn surface area 1%～26%; Shallow II degree 108 examples, dark II degree 49 examples, III degree 16 examples; The burn position, upper limb 86 examples, lower limb 52 examples, women's head-ornaments portion 7 examples, trunk 28 examples; Burn cause, hydrothermal solution are scalded 96 examples, and steam is scalded 13 examples, flame burn 14 examples, and low temperature burn 37 examples, electric arc is hindered 2 examples, electric burn 1 example, chemical burn 10 examples; 1 hour～117 days burn time; Diabetic history 0.5～28 year; 37 examples make insulinize, 61 routine oral antidiabetic drug, and 75 routine patients know the also medication seldom of own blood glucose height; Record blood glucose at 8.6mmol/L～12.6mmol/L.
Two, diagnostic criteria
Palm test is adopted in the burn surface area estimation.
The burn degree adopts three degree quarterings, and promptly the depth according to skin burn is divided into I degree, shallow II degree, dark II degree, III degree, reaches muscle, sclerotin injury person deeply and still calculates by the III degree.Convenient for expressing clinically, I degree and shallow II degree are called shallow burn, dark II degree and III degree are called dark burn.
I degree burn: claim erythematous burn, only injure epidermis shallow-layer----horny layer, clear layer, granular layer or injure stratum aculeatum, but genetic horizon is alive, local rubescent, little swollen, causalgia, no vesicle.
Shallow II degree burn: claim the vesicle burn again, ruin and part stratum germinativum or papillary layer of corium, hinder red, swollen, the severe pain in district, vesicle or epidermis occur and separate with corium, include blood plasma sample yellow liquid, wound surface was scarlet, moistening after vesicle was removed, pain is more acute, it is many to ooze out.
Deep ii degree burn: except that epidermis, whole papillary layer of corium burn, reticular layer of corium is partly got involved, the hair follicle and the sweat gland that are positioned at the corium deep layer still have vigor, after the vesicle skin breaks or removes beancurd sheet, it is red thoroughly in white that wound surface is, that vasoganglion, wound surface red and white or visible tiny thromboembolism ooze out is many, edema is obvious, hypalgesia, hair pulling test hypodynia.
III degree burn: claim eschar burn again, epiderm skin and corium holostrome are ruined, reach subcutaneous tissue deeply, even muscle, skeleton also damages, one deck slough that forms on the wound surface is called eschar, be pale asphyxia, yellow-white, sallow or coke black, the eschar of dry, hard can be the leather sample, and can seeing on the eschar, the venae subcutaneae net of thromboembolism is dendroid, wound surface analgesis, hair pulling test is drawn out easily and does not feel pain.
Three, criterion of therapeutical effect
Cure: wound surface heals fully.
Take a turn for the better: the most of healing of wound surface, the residue wound surface does not have obvious infection.
Invalid: the undesirable or accompanying infection of wound healing.
Four, Therapeutic Method and therapeutic outcome
(1) exposes Sex therapy
Be applicable to head, face, cervical region or at any position that do not suffer oppression of 22～40 ℃.
I degree burn: spread 0.5～1.0 millimeter medicine of the present invention after being coated with sticking medicament (as erythromycin cream or burn analgesic extract etc.), can heal in 3～7 days.
Shallow II degree burn: peeling, treatment form grey black mucus with I degree burn under the crust after three days, women's head-ornaments portion can heal in 5～7 days, and the upper limb trunk can be healed in 8～11 days, and lower limb can be healed in 10～12 days.
Dark II degree or III degree burn: peeling, treatment was changed dressings once with I degree burn in 8～12 days, removed floating crust when changing dressings, and gently was stained with unnecessary mucus but wound surface not capable of washing with absorbent cotton, and healing time is relevant with the wound surface size depth, but repeatable operation, until healing.
(2) occlusive dressing
Be applicable to head, face, cervical region any position in addition, be not subjected to the restriction of temperature and external environment.
Therapeutic Method is basic with exposing Sex therapy, difference is, application ethacridine gauze one deck (this gauze and medicine Fails To Respond of the present invention again on medicine of the present invention, purpose separates medicine of the present invention and Cotton Gossypii), add a cover 0.2～0.6 centimetre of aseptic cotton again and cover, be integrated with gauze, wrapping linear slit.I degree burn once can be healed in 3～7 days, and shallow II degree burn once can be healed in 8～12 days, and dark II degree or III degree burn were changed dressings once in 10～15 days, can use repeatedly until recovery from illness, to the osteonecrosis patient in conjunction with operative treatment.
Illustrate:
There have mucus to belong on the yarn cotton when (1) dark II degree or III degree burn are changed dressings to be normal, and this is the slough and the medicine of liquefaction, newborn nutraceutical mixture, and available Cotton Gossypii gently is stained with the unnecessary mucus of wound surface, and wrapping is handled, and promptly is " snuggling up to pus raw meat " that the traditional Chinese medical science is said.
(2) no matter be to expose or occlusive dressing, not capable of washing to wound surface, sticking medicament has only for the first time to be used; Clean wound surface regrowth is played destruction, secondary uses sticking medicament can reduce local temperature and destroys blood circulation.
Five, statistical result
Wherein, in normally aing burn case: once cure 637 examples, healing in average 11 days; Twice healing, 328 people, healing in average 22 days; Cure 196 people 3～4 times, healing in average 34 days; 7 examples that take a turn for the better, average 50 days; 1 example is excessive because of the age, and body constitution is poor, and self skin does not have regeneration capacity and is invalid;
During diabetes a burn case: once cure 108 examples, healing in average 11 days; Twice healing, 32 people, healing in average 26 days; Cure 30 people 3～4 times, healing in average 35 days; 86 days complete healing of the longest example; 1 example that takes a turn for the better, average 52 days; 1 example is transferred from one hospital to another because of osteonecrosis.Healing time is compared basic synchronization with its normal person.
From above-mentioned clinical statistics result as can be known, medicine of the present invention is 99.9% to the effective percentage of normal burn, and the effective percentage that diabetes are burnt is 99.4%, and the healing time aspect, diabetes fire victim and normal fire victim's basic synchronization.
Model case
Case 1
Song, the man, 37 years old, Gu Jin Lou Song people from village, in January, 2009, flame burn came here to go to a doctor, and was diagnosed as upper and lower extremities, the shallow II degree of trunk, dark II degree mixing burn, burn surface area 39%.Adopt occlusive dressing, peeling, spread 0.5 millimeter embodiment 1 medicine after being coated with sticking medicament erythromycin cream, apply one deck ethacridine gauze (this gauze and medicine Fails To Respond of the present invention, purpose separates medicine of the present invention and Cotton Gossypii), adding a cover 0.3 centimetre of aseptic cotton again covers, be integrated with gauze, wrapping linear slit, disposable no cicatrix was cured burn surface area 35% in 11 days, do not re-use erythromycin cream after for the second time beginning to change dressings, remove floating crust when changing dressings, gently be stained with unnecessary mucus but wound surface not capable of washing with absorbent cotton, changed dressings once healing after the repeatable operation 3 times in 11 days.
Case 2
Often so-and-so, the man, 4 years old, moderately well-off people from village of Nanyue County West St, scalded by boiled water in March, 2009, comes here to go to a doctor, and is diagnosed as cervical region I degree, shallow II degree mixes burn, burn surface area 11%.Adopt to expose Sex therapy, 0.8 millimeter embodiment 2 medicine is spread after being coated with sticking medicament erythromycin cream in the affected part, and disposable no cicatrix is cured after 8 days.Case 3
Go into business so-and-so, the woman, 42 years old, the Zhongyuan Oil Field worker, in JIUYUE, 2009 comes here to go to a doctor because of natural gas burn, is diagnosed as upper limb trunk deep ii degree burn area 31%, III degree burn surface area 5%, the burn gross area 36%.Adopt occlusive dressing, the affected part peeling, spread 1.0 millimeters embodiment 3 medicines after being coated with the conventional burn cream of sticking medicament, apply one deck ethacridine gauze (this gauze and medicine Fails To Respond of the present invention, purpose separates medicine of the present invention and Cotton Gossypii), adding a cover 0.6 centimetre of aseptic cotton again covers, be integrated with gauze, wrapping linear slit, changed dressings once in 12 days, the healing burn surface area 30% of changing dressings does not for the first time re-use burn cream after for the second time beginning to change dressings, and removes floating crust when changing dressings, gently be stained with unnecessary mucus but wound surface not capable of washing with absorbent cotton, change dressings repeatedly the operation 3 times after the healing.
Case 4
Appoint so-and-so, the man, 55 years old, Ji Gan people from village, Zhang Guotun township hindered because of electric arc, comes the here diagnosis, is diagnosed as upper limb trunk deep ii degree burn area 3%, III degree burn surface area 8%.Patient's private prosecution was simultaneously previously suffered from diabetes 5 years, but do not obey any antidiabetic drug over the past two years, treatment before measurement blood glucose is about 10.6mmol/L, adopt occlusive dressing not take any hypoglycemic drug simultaneously, the affected part peeling, spread 0.9 millimeter embodiment 3 medicine after being coated with sticking medicament erythromycin cream, apply one deck ethacridine gauze (this gauze and medicine Fails To Respond of the present invention, purpose separates medicine of the present invention and Cotton Gossypii), adding a cover 0.5 centimetre of aseptic cotton again covers, be integrated with gauze, wrapping linear slit, changed dressings once in 13 days, the more burn surface area 3% of changing dressings for the first time.Do not re-use erythromycin cream after for the second time beginning to change dressings, remove floating crust when changing dressings, gently be stained with unnecessary mucus but wound surface not capable of washing, 4 (each 13 days) back healings of operation of changing dressings repeatedly with absorbent cotton.
Case 5
The king so-and-so, the woman, 43 years old, first villages and small towns Cai Zhuan people from village because of chemical burn, came here to go to a doctor, and was diagnosed as the shallow II degree burn of the back of the hand, burn surface area 21%.Patient's private prosecution was simultaneously previously suffered from diabetes 3 years and often oral antidiabetic drug, insulin injection treatment.Treatment before measurement blood glucose is about 11.6mmol/L, adopts exposure method to stop insulinize, not blood sugar control simultaneously, the affected part peeling, spread 1.0 millimeters embodiment 2 medicines after being coated with sticking medicament erythromycin cream, form grey black mucus after 3 days under the crust, disposable no cicatrix is cured after 11 days.
Claims (5)
1. a Chinese and western medicinal composition for the treatment of burn is characterized in that being made up of following parts by weight of traditional Chinese medicines and Western medicine: 80～120 parts of Rhizoma Coptidis, 800～1200 parts of medicinal charcoal, 8～12 parts of Borneolum Syntheticums, 80～120 parts of big Corium elephatiss, 60～90 parts in chloromycetin, 3～7 parts of vitamin Bies, 80～120 parts of furazolidones, 230～270 parts of oxytetracyclines, 30～70 parts of griseofulvin.
2. the Chinese and western medicinal composition of treatment burn as claimed in claim 1 is characterized in that being made up of following parts by weight of traditional Chinese medicines and Western medicine: 100 parts of Rhizoma Coptidis, 1000 parts of medicinal charcoal, 10 parts of Borneolum Syntheticums, 100 parts of big Corium elephatiss, 75 parts in chloromycetin, 3 parts of vitamin Bies, 100 parts of furazolidones, 250 parts of oxytetracyclines, 50 parts of griseofulvin.
3. the Chinese and western medicinal composition of treatment burn as claimed in claim 1 or 2 is characterized in that: described medicinal charcoal replaces with the agysical that contains the equivalent medicinal charcoal.
4. the Chinese and western medicinal composition of treatment burn as claimed in claim 1 or 2, it is characterized in that: described big Corium elephatis is the big Corium elephatis of concocting.
5. the Chinese and western medicinal composition of treatment burn as claimed in claim 3, it is characterized in that: described big Corium elephatis is the big Corium elephatis of concocting.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102056751A CN101850000B (en) | 2010-06-22 | 2010-06-22 | Chinese and western medicinal composition for treating empyrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102056751A CN101850000B (en) | 2010-06-22 | 2010-06-22 | Chinese and western medicinal composition for treating empyrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101850000A CN101850000A (en) | 2010-10-06 |
| CN101850000B true CN101850000B (en) | 2011-07-27 |
Family
ID=42801789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102056751A Expired - Fee Related CN101850000B (en) | 2010-06-22 | 2010-06-22 | Chinese and western medicinal composition for treating empyrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850000B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463136B (en) * | 2013-09-04 | 2019-05-21 | 王宝凤 | A kind of ointment for burns and scalds and preparation method thereof |
| CN105381101A (en) * | 2015-12-03 | 2016-03-09 | 张东 | Medicine used for treating burns, scalds and bedsore and preparation method thereof |
| CN105853414A (en) * | 2016-03-31 | 2016-08-17 | 陈孟根 | Externally-applied combined drug used for rapidly healing burns and scalds, and application thereof |
| CN106421129A (en) * | 2016-12-13 | 2017-02-22 | 蓝莹 | Traditional Chinese medicine composition for treating scald |
| CN107625832A (en) * | 2017-09-27 | 2018-01-26 | 覃益祥 | A kind of Chinese medicine composition for alleviating scald |
| CN107753791A (en) * | 2017-12-06 | 2018-03-06 | 苏州科技城医院 | Treat the Chinese and western medicinal composition of burn |
| CN109172583A (en) * | 2018-08-27 | 2019-01-11 | 康宗华 | A kind of pharmaceutical composition for burn and scald knife wound and preparation method thereof and purposes |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1125139A (en) * | 1995-12-06 | 1996-06-26 | 张金安 | Antiphlogistic analgesic ointment for treating burn |
-
2010
- 2010-06-22 CN CN2010102056751A patent/CN101850000B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1125139A (en) * | 1995-12-06 | 1996-06-26 | 张金安 | Antiphlogistic analgesic ointment for treating burn |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101850000A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101850000B (en) | Chinese and western medicinal composition for treating empyrosis | |
| US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
| CN102397376B (en) | Chinese medicinal composition for treating dysmenorrhea and compound supercritical fluid extract | |
| CN103893557A (en) | Traditional Chinese medicine preparation for treating bedsore | |
| TW200942270A (en) | Chinese medicine composition for treatment of wounds or bedsore, and method for producing preparation thereof | |
| CN105456326A (en) | Traditional Chinese medicine for treating scalds as well as preparation method and application of traditional Chinese medicine | |
| CN103446240B (en) | Traditional Chinese medicine composition for rapidly healing wounds | |
| CN101028365B (en) | Medicine for treating burn and ambustion and its production | |
| CN104324261A (en) | Pharmaceutical composition for treating high blood sugar and preparation method of pharmaceutical composition | |
| CN104840557B (en) | A kind of traditional Chinese medicine tea for being used to treat primary dysmenorrhea | |
| CN102133286B (en) | Ointment for treating trauma and preparation method thereof | |
| WO2011044736A1 (en) | Pharmaceutical composition for treating skin injury, preparation method of its ointment and use thereof | |
| CN104147315A (en) | Emulsion medicine for treating scald and burn and preparation method thereof | |
| CN1969996A (en) | Chinese medicinal powder having functions in stopping bleeding, relieving pain, diminishing swelling and promoting granulation and preparation process thereof | |
| CN101077360B (en) | Medicinal composition for treating sugar diabetes skin ulcer and preparation method thereof | |
| CN104740543B (en) | A kind of medicine for treating flat wart | |
| CN100369612C (en) | External-use powder medicine for wetting burn and empyrosis and its preparing method | |
| CN103768408A (en) | Medicine for preventing and treating pains after operations due to anorectal diseases | |
| CN102920818B (en) | Formula of medicine for treating burn, scald and cold injury | |
| CN109419868A (en) | A kind of externally applied drug for treating soft tissue injury | |
| CN102319271A (en) | A kind of nursing care of decubitus ulcer powder | |
| CN101700292B (en) | Traditional Chinese medicine composite for curing lymphatic tuberculosis | |
| CN105726682A (en) | Traditional Chinese medicine for treating trauma and preparation method thereof | |
| CN105288050A (en) | Medicine for treating cancer | |
| CN100551411C (en) | Medicine powder for healing wound fast |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110727 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |